3,5-Difluoropyridine-4-carboxylic acid | CAS:903522-29-2

We serve 3,5-Difluoropyridine-4-carboxylic acid CAS:903522-29-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3,5-Difluoropyridine-4-carboxylic acid

Chemical Name:   3,5-Difluoropyridine-4-carboxylic acid
CAS.NO: 903522-29-2
Synonyms:3,5-Difluoro-4-carboxypyridine;
4-CARBOXY-3,5-DIFLUOROPYRIDINE;
ABBYPHARMA AP-16-5133;
3,5-difluoro-4-pyridinecarboxylic acid;
3,5-difluoroisonicotinic acid;
Molecular Formula:C6H3F2NO2
Molecular Weight: 159.09000
 
Physical and Chemical Properties:
Density: 1.535g/cm3
Melting point: /
Boiling point:316.9ºC at 760 mmHg
Flash point: 145.5ºC
Index of Refraction:1.515
 
Specification:
Appearance:  Yellow liquid
Purity:≥99.0%
 
Packing:25kg/drum
Storage:Store in a tightly closed container. Store in a cool, dry.
Application:     used in the Pharmaceutical Industrial



Contact us for information like 3,5-Difluoropyridine-4-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,5-difluoroisonicotinic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,5-Difluoropyridine-4-carboxylic acid Use and application,3,5-Difluoro-4-carboxypyridine technical grade,usp/ep/jp grade.


Related News: The second is known as the excipient, which is the inactive substance that serves as the vehicle for the API itself.Phthalimide manufacturer The second is known as the excipient, which is the inactive substance that serves as the vehicle for the API itself.(S,Z)-5-Amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one supplier As many as 9,000 medical workers in Hong Kong have pledged to strike this week, a threat that alarms the territory’s officials as they are struggling to contain the coronavirus outbreak.2-bromo-5-fluoro-4-methyl-3-nitropyridine vendor Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as “bulk pharmaceutical chemicals (BPCs).”